Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 15862817
[patent_doc_number] => 20200138812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => LIVER X RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/418339
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16418339
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/418339 | LIVER X RECEPTOR MODULATORS | May 20, 2019 | Abandoned |
Array
(
[id] => 14808233
[patent_doc_number] => 20190270726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PRODUCTS OF CHIRAL SYNTHESIS OF CIS-IMIDAZOLINE COMPOUNDS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/415862
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415862 | PRODUCTS OF CHIRAL SYNTHESIS OF CIS-IMIDAZOLINE COMPOUNDS AND THEIR USE | May 16, 2019 | Abandoned |
Array
(
[id] => 17005313
[patent_doc_number] => 20210236474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMIDAZO[4,5-C]PYRIDINE COMPOUNDS AS LSD-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/052626
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052626 | Imidazo[4,5-c]pyridine compounds as LSD-1 inhibitors | May 12, 2019 | Issued |
Array
(
[id] => 15483163
[patent_doc_number] => 10556914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/409323
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42042
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16409323
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/409323 | Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of use | May 9, 2019 | Issued |
Array
(
[id] => 17896967
[patent_doc_number] => 20220306629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/054468
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 183719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054468 | NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE | May 9, 2019 | Pending |
Array
(
[id] => 14746605
[patent_doc_number] => 20190256476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/404481
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404481 | Compositions and methods for inhibition of the JAK pathway | May 5, 2019 | Issued |
Array
(
[id] => 17020869
[patent_doc_number] => 20210244740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => INHIBITORS OF RSV REPLICATION AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/052595
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16311
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 249
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052595 | Inhibitors of RSV replication and applications thereof | May 2, 2019 | Issued |
Array
(
[id] => 15083407
[patent_doc_number] => 20190336514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/402589
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402589
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402589 | KRAS G12C inhibitors and methods of using the same | May 2, 2019 | Issued |
Array
(
[id] => 15086239
[patent_doc_number] => 20190337930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => SYNTHESIS OF CERDULATINIB
[patent_app_type] => utility
[patent_app_number] => 16/402880
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9167
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402880
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402880 | Synthesis of cerdulatinib | May 2, 2019 | Issued |
Array
(
[id] => 16428240
[patent_doc_number] => 10828301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => 2,4-pyrimidinediamine compounds and their uses
[patent_app_type] => utility
[patent_app_number] => 16/402912
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 139603
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402912 | 2,4-pyrimidinediamine compounds and their uses | May 2, 2019 | Issued |
Array
(
[id] => 19042272
[patent_doc_number] => 11931345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases
[patent_app_type] => utility
[patent_app_number] => 17/052791
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 33
[patent_no_of_words] => 29793
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052791
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052791 | Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases | May 2, 2019 | Issued |
Array
(
[id] => 15468485
[patent_doc_number] => 10550105
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Pyridazinones as PARP7 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/397103
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 145250
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397103 | Pyridazinones as PARP7 inhibitors | Apr 28, 2019 | Issued |
Array
(
[id] => 14808299
[patent_doc_number] => 20190270759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => HETEROARYL INHIBITORS OF PDE4
[patent_app_type] => utility
[patent_app_number] => 16/396457
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396457 | Heteroaryl inhibitors of PDE4 | Apr 25, 2019 | Issued |
Array
(
[id] => 15646583
[patent_doc_number] => 20200085821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME
[patent_app_type] => utility
[patent_app_number] => 16/391534
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 180196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391534
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391534 | Heteroaryl compounds useful as inhibitors of SUMO activating enzyme | Apr 22, 2019 | Issued |
Array
(
[id] => 15023337
[patent_doc_number] => 20190322673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => PTERIDINONE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/391407
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 142610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391407 | Pteridinone compounds and uses thereof | Apr 22, 2019 | Issued |
Array
(
[id] => 14682225
[patent_doc_number] => 20190240227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/387187
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16387187
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/387187 | THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF | Apr 16, 2019 | Abandoned |
Array
(
[id] => 14777727
[patent_doc_number] => 20190263761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/386364
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16386364
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/386364 | SUBSTITUTED TRIAZINES AND A METHOD FOR PRODUCING SAME | Apr 16, 2019 | Abandoned |
Array
(
[id] => 16793053
[patent_doc_number] => 20210122870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => AQUEOUS DISPERSION OF A POLYURETHANE COMPRISING A DICARBOXYLATE WITH ONE OR TWO SECONDARY AMINO GROUP
[patent_app_type] => utility
[patent_app_number] => 17/050744
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050744
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/050744 | AQUEOUS DISPERSION OF A POLYURETHANE COMPRISING A DICARBOXYLATE WITH ONE OR TWO SECONDARY AMINO GROUP | Apr 14, 2019 | Pending |
Array
(
[id] => 14962925
[patent_doc_number] => 20190308940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => 2-AMINOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/382816
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382816
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382816 | 2-aminopyrimidine derivatives for the treatment of viral infections | Apr 11, 2019 | Issued |
Array
(
[id] => 14993619
[patent_doc_number] => 20190315767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => TRICYCLIC ASK1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/382936
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382936 | Tricyclic ASK1 inhibitors | Apr 11, 2019 | Issued |